Man suffering with Chron's calls on Bromley Sainsbury's to reopen toilets
A South Londoner with Crohn's disease has called on Sainsbury's to reopen toilets in its Bromley superstore, saying people like him are being limited without easy access to the facilities.
While one disabled toilet remains open at the supermarket in Walters Yard, the closure of the main toilets following vandalism and 'misuse' means asking a member of staff for the key.
In Olly Russell's case, that means he feels 'limited' because he fears being caught short.
Olly Russell
The 41-year-old, who lives in Shortlands, told the Local Democracy Reporting Service (LDRS): 'Having access to a toilet is incredibly important because sometimes you get caught short and you just have to go.
'If you only have one toilet for everybody – so people with physical disabilities, people with unseen disabilities, mothers with their children, all of that – it's not workable.'
Crohn's is a type of inflammatory bowel disease that causes parts of the gut to become inflamed, swollen, and ulcerated. Symptoms include gut pain, diarrhoea, weight loss and fatigue.
Mr Russell believes that the toilet closure will negatively affect customers with medical conditions like Crohn's, as well as the elderly and parents with young children.
In response to Sainsbury's decision to close the toilets over their misuse and vandalism, Mr Russell said that staff and security guards at the store should take more notice of the toilets on a day-to-day basis in order to prevent any misuse from occurring.
He said: 'With Sainsbury's doing this, it will eventually affect their bottom line. Maybe not in a very clear way, but for a certain subset of people who do have disabilities, it can change where you go to shop.
'I'm not asking for any real special treatment. All I want is the option for a toilet I can just access instantly without a passcode or without a key or without some sort of rigmarole because often, you've not got much time.'
Sam Webber, a Liberal Democrat Bromley councillor, has also criticised the closure.
He feared that if the Sainsbury's toilets in Bromley continue to remain closed, it could have a domino effect on the supermarket chain's other stores in the borough, such as the ones in Beckenham, Penge, Orpington, Chislehurst and Locksbottom.
Cllr Webber said: 'I raised this issue in the Bromley Council chamber because I am very concerned about the impact on our most vulnerable residents.
"Those with conditions like Crohn's, as well as elderly residents and those with children, should not be forced to queue up and request a key for the disabled toilet in the Bromley Sainsbury's store.
'I am even more concerned that the other five Sainsbury's superstores will gradually see their toilets closed too. I hope Sainsbury's will now think again on this. If not, I suspect many of their customers will be voting with their feet and shopping elsewhere.'
Marianne Radcliffe, CEO of charity Crohn's & Colitis UK, said: 'Public toilets are vital for people living with Crohn's and colitis, because symptoms include needing to use the loo frequently and urgently.
"While it is good that an accessible toilet will still be available at this supermarket, customers will still have to spend time finding a staff member to get a key to open it. And that will be challenging due to needing toilet access quickly.
'Crohn's and colitis are among a number of invisible conditions, so it is important to remember that someone may look fine, but need toilet access urgently; not every disability is visible. Crohn's & Colitis UK works in partnership with other charities as part of the London Loo Alliance to remind people that toilet access plays a crucial part in making sure London is the welcoming city we all need it to be.'
In response to the concerns raised by Mr Russell, a Sainsbury's spokesperson said: 'Due to ongoing challenges with misuse, we made the difficult decision to close some of the toilets at our Bromley store last year and are sorry for any inconvenience this may cause.
"Our accessible toilet remains available for customers who may need it, with our colleagues on hand to provide access.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
17 hours ago
- Yahoo
Nine unusual and delicious ideas for strawberries
The arrival of British strawberries is one of the most delicious signs that summer has begun. And this year, berry lovers are in for a treat: it's shaping up to be an exceptional season. According to Sandy Booth, CEO of New Forest Fruit Co – a key supplier for Sainsbury's – the sunny weather has worked wonders. 'With the recent spell of sunshine, our strawberries are ripening at a faster rate than usual, not only giving us a bumper crop but also yielding fruit with enhanced sweet and juicy flavours due to the cooler nights, after long sunny days,' he says. More than 30 varieties are grown across the country, but most supermarkets either don't list the variety on the label or default to the reliably firm and sweet Elsanta. Look a little further and you'll find other cultivars, such as the aromatic Eve's Delight from Kent (currently at M&S for £8.33/kg). But if you're simply planning to slice and serve with cream, save a few pence and pick up a punnet of Waitrose's 'wonderfully wonky' but fabulously sweet berries (£7.20/kg). But why stop at cream? Piled onto a pavlova, muddled in a jug of Pimm's or stirred through an Eton Mess are just a few of the strawberry's starring roles; there's no shortage of ways to enjoy this year's giant, juicy berries, as you'll discover below. A quick note before you tuck in: to enjoy strawberries at their best, store them properly. Don't wash them first – simply refrigerate in their original container, or, if they came in a paper bag, transfer to a shallow bowl lined with kitchen paper. For full flavour, bring them to room temperature at least an hour before serving. These make a fab addition to a charcuterie board and the leftover juices can be whisked with olive oil for a zingy salad dressing. Hull and halve 400g strawberries and place in a jar. Warm together 150ml white wine vinegar, 75ml water, 3 tbsp caster sugar. Add your choice of whole spices, such as a sprinkle of pink or black peppercorns, a couple of star anise, cracked cardamom pods or a pinch of chilli flakes. Stir until the sugar dissolves then pour over the strawberries. Leave to cool to room temperature then chill until ready to serve. Keep chilled and eat within two days. For a surprisingly wonderful flavour match, swap the cherry tomatoes in your traditional tricolore salad for sweet and juicy strawberries. Or to make delicious pre-dinner nibbles to serve alongside a glass of summer spritz, thread small or halved strawberries, mini mozzarella and basil leaves onto cocktail sticks and finish with a drizzle of balsamic glaze. Butter two slices of brioche bread and make a sandwich (butter on the outside) with goat's cheese and sliced strawberries. Season with chilli flakes, black pepper and a drizzle of honey if you fancy it, then toast in a panini press or frying pan until crunchy and golden brown. For neat and speedy removal, gently push a straw, preferably a thin metal or reusable plastic one, through the tip of the strawberry. The calyx will simply pop out of the top. Place 400g halved strawberries, 2 tsp sumac, 1 tsp vanilla extract, 2 tbsp caster sugar and 4 tbsp water in a small heatproof dish. Stir well then roast or air fry at 200C for 15-20 minutes until softened and bubbling but still holding their shape. Wonderful served with yoghurt for breakfast or ice cream for pudding. Homemade creamy strawberry ice lollies need only three ingredients and an overnight stint in the freezer (no additives or emulsifiers in these, thank you). Hull and halve 300g strawberries and blend with 170g condensed milk and 100ml milk until smooth. For seedless lollies, strain the mixture, otherwise pour into 6 ice lolly moulds and freeze overnight. For a pretty summer salad, toss together halved strawberries, diced or sliced ripe avocado and some baby spinach leaves. Crumble in a little feta, add a few slivers of red onion then dress with a honey-mustard vinaigrette. Thoroughly dry the strawberries by patting with kitchen paper then remove the hull. Push in a cocktail stick then freeze the strawberries in a single layer. Dip the frozen strawberries into melted white chocolate, using the stick to shake off any excess. Once all the strawberries are coated, return to the freezer until fully set then repeat with a layer of milk or dark chocolate then slide out the sticks. Serve frozen. Roughly chop 12 large strawberries and 2 limes and muddle together in a jug with two tablespoons of white sugar and few fresh mint leaves. Stir in 400ml white rum, mixing well. When ready to serve, divide between 6-8 glasses, fill with ice cubes then top up with sparkling water. Fill a blender goblet with hulled and halved strawberries (if you have any other berries such as raspberries or blueberries, add a few of those too). Break in a small banana then add a good splash of milk or coconut milk or water and whizz until smooth. Pour over ice and serve. Broaden your horizons with award-winning British journalism. Try The Telegraph free for 1 month with unlimited access to our award-winning website, exclusive app, money-saving offers and more.
Medscape
17 hours ago
- Medscape
Intestinal Ultrasound Wins in Early Crohn's Prognosis
Findings on intestinal ultrasound (IUS) are useful for predicting remission in recent-onset Crohn's disease (CD), a prospective, population-based cohort of newly diagnosed patients in Denmark reported. Adding to the growing body of evidence on the utility of this noninvasive imaging tool in monitoring disease activity in the newly diagnosed, the multicenter study published in Clinical Gastroenterology and Hepatology characterized ultrasonographic features at diagnosis and evaluated IUS's prognostic value. Existing literature has focused on patients with long-standing disease. Investigators led by first author Gorm R. Madsen, MD, PhD, of the Copenhagen Center for Inflammatory Bowel Disease in Children, Adolescents and Adults at Copenhagen University Hospital, observed continued improvement in most IUS parameters throughout the first year. 'Our findings thereby emphasize the role of IUS in improving patient management, and its use in patient risk stratification already at diagnosis,' the investigators wrote. Some 38% of patients reached ultrasonic transmural remission within 3 months of diagnosis, an achievement associated with higher rates of sustained steroid-free clinical remission and reduced need for treatment escalation. 'Ultrasonic transmural remission is achievable early in Crohn's disease and is associated with favorable outcomes, underscoring the value of intestinal ultrasound in early disease management,' the researchers wrote. Study Details While IUS is increasingly recognized for monitoring CD, little was known about its prognostic value early in the disease course. 'We aimed to determine whether sonographic inflammation at diagnosis — and particularly the achievement pftransmural remission after 3 months — could predict future outcomes,' Madsen told Medscape Medical News . 'This is important, as early identification of patients at risk of surgery or treatment escalation may help guide therapy decisions more effectively.' From May 2021 to April 2023, 201 patients (mean age, 35 years; 54.2% men) with new adult-onset CD were followed by IUS and monitored with symptomatic, biochemical, and endoscopic evaluations. After 3 months, transmural remission was achieved more often by patients with colonic disease, and no associations were found between sonographic inflammation at diagnosis and diagnostic delay. 'We were positively surprised. Nearly 40% of newly diagnosed Crohn's patients achieved transmural remission within 3 months — a higher proportion than seen in earlier studies, which mostly focused on long-standing or trial-selected populations,' Madsen said. 'It was also striking how strongly early IUS findings predicted the need for surgery, outperforming endoscopy and biomarkers.' In other findings, transmural remission at 3 months was significantly associated with steroid-free clinical remission at both 3 months and all subsequent follow-ups within the first year. It was also linked to a lower risk for treatment escalation during the follow-up through to 12 months: 26% vs 53% ( P =.003). At 12 months, 41% had achieved transmural remission. Higher baseline body mass index significantly reduced the likelihood of 12-month transmural remission. For overweight, the odds ratio (OR) was 0.34 (95% CI, 0.12-0.94), while for obesity, the OR was 0.16 (95% CI, 0.04-0.73). The International Bowel Ultrasound Segmental Activity Score in the terminal ileum at diagnosis emerged as the best predictor of ileocecal resection during the first year, with an optimal threshold of 63 (area under the curve, 0.92; sensitivity, 100%; specificity, 73%). The use of IUS has expanded considerably in the past 3 years, and in 2024, the American Gastroenterological Association updated its clinical practice guidance on the role of this modality in inflammatory bowel disease. IUS is noninvasive, radiation-free, inexpensive, and doable at the bedside with immediate results, Madsen said. 'For patients, this means less anxiety and discomfort. For healthcare systems, it enables faster clinical decisions, reduced need for endoscopy or MRI, and closer disease monitoring, particularly valuable in treat-to-target strategies.' In terms of limitations, however, IUS is operator-dependent and consistent training is crucial, he added. 'Certain anatomical regions, particularly the proximal small bowel, can be more challenging to evaluate. Additionally, while IUS is highly effective for assessing inflammatory activity, it becomes more difficult to accurately assess disease involvement when inflammation extends beyond approximately 20 cm of the small bowel.' Key Insights Commenting on the Danish study from a US perspective, Anna L. Silverman, MD, a gastroenterology fellow at Icahn School of Medicine at Mount Sinai in New York City, agreed the findings in adult patients with newly diagnosed, rather than long-standing, CD contribute to the growing body of evidence supporting IUS's applicability for both treatment monitoring and prognosis. 'By focusing on early-stage CD, the study provides clearer insights into initial disease activity and response to therapy, reinforcing the value of this noninvasive, point-of-care modality,' she told Medscape Medical News . 'These findings enhance our understanding of IUS as a tool to help guide early management decisions in CD.' Ashwin Ananthakrishnan, MBBS, MPH, director of the Crohn's and Colitis Center at Massachusetts General Hospital and an associate professor at Harvard Medical School, both in Boston, concurred that this is an important study. 'It includes newly diagnosed patients — so a very 'clean' cohort in terms of not being influenced by confounders,' he told Medscape Medical News . 'We don't fully know yet the best treatment target in CD, and this study highlights the importance of early transmural healing in determining outcomes at 1 year,' he noted. In addition, the study highlighted a convenient tool that can increasingly be applied at point of care in the United States. 'Colonoscopy at 3 months is not practical and has low patient acceptability, so using IUS in this circumstance would have value and impact.' Ananthakrishnan pointed to several unanswered questions, however. 'Are there patients who may not have healing early but may take some extra time to achieve transmural remission, and if so, what are their outcomes? What is the best timepoint for transmural healing assessment? What is the incremental value of measuring it at 3 vs 6 months?' In addition, he wondered, how much is the added value of IUS over clinical symptoms and/or markers such as calprotectin and C-reactive protein? 'In the subset of patients with clinical and transmural remission, there was no difference in endoscopic outcomes at 1 year, so this is an unanswered question,' Ananthakrishnan said. This study was funded by an unrestricted grant from the Novo Nordisk Foundation.
Medscape
18 hours ago
- Medscape
Fitness Levels Impaired in Patients With Paediatric IBD
Patients with paediatric inflammatory bowel disease (IBD) exhibited lower cardiorespiratory and neuromuscular fitness than healthy matched control participants. Higher body mass index (BMI) for children and adolescents was negatively associated with cardiorespiratory fitness, while the use of any biologic medication was positively associated. METHODOLOGY: This cross-sectional case-control study assessed cardiorespiratory and neuromuscular fitness in patients with paediatric IBD aged 6-17 years. This study included 73 patients with paediatric IBD (mean age, 13 years; 56.2% girls; 31 with Crohn's disease [CD]; 42 with ulcerative colitis [UC] and IBD unidentified) from two tertiary centres in Finland and 73 age- and sex-matched healthy control children from an ongoing study and registry. Clinical disease activity was determined using the Pediatric Ulcerative Colitis Activity Index for UC and using the Pediatric Crohn's Disease Activity Index for CD along with the Physician's Global Assessment, and physical activity was evaluated using a questionnaire covering various activities over the past 12 months. Cardiorespiratory fitness was measured with a maximal exercise test on a cycle ergometer. Peak oxygen uptake (VO2peak) and maximal workload (Wmax) divided by body weight were considered as measures of cardiorespiratory fitness. Neuromuscular fitness was also assessed using various tests. TAKEAWAY: All patients with CD were in remission or had mild disease activity, whereas 69% of patients with UC were in remission and only one had a severe disease. Patients with paediatric IBD had significantly lower cardiorespiratory fitness, with lower Wmax/kg ( P = .007) and VO2peak/kg ( P < .001) than control participants. = .007) and VO2peak/kg ( < .001) than control participants. Neuromuscular fitness was also reduced in patients with paediatric IBD, with lower performance than control participants in sit-up, long jump, and hand grip strength tests ( P = .001 for all). = .001 for all). In the multivariate analysis, higher age‐ and sex‐adjusted BMI for children and adolescents was associated with lower Wmax/kg and VO2peak/kg ( P < .001 for both), while the use of any biologic medication was linked to higher Wmax/kg ( P = .025) and VO2peak/kg ( P = .006). IN PRACTICE: "Lower physical fitness has been associated with poorer disease control, impaired quality of life, and increased risk of cardiovascular diseases in PIBD [paediatric IBD]. This emphasizes the importance of assessing and improving physical fitness in these patients as a part of their multidisciplinary treatment," the authors wrote. SOURCE: This study was led by Saija Kantanen, Tampere University Hospital, Tampere, Finland. It was published online on May 30, 2025, in the Journal of Pediatric Gastroenterology and Nutrition . LIMITATIONS: Some data from the control group were collected previously, and changes in physical activity levels over time may have affected the results. Additionally, the duration of the disease in patients was short, and the design was cross-sectional. DISCLOSURES: This study was supported by the Foundation for Pediatric Research; the State Funding for University-level Health Research, Tampere University Hospital, and Wellbeing Services County of Pirkanmaa; the Päivikki and Sakari Sohlberg Foundation; and the Finnish Foundation for Cardiovascular Research. The authors declared having no relevant conflicts of interest.
